Table 3.
Drug |
Voltage-dependent block |
Inactivated-state block | |
---|---|---|---|
HP −140 mV IC50 (μM); Kr | HP −70 mV IC50 (μM); K−70 | Calculated Ki (μM) | |
Mex | 147.9±20.0 | 1.9±0.2 | 1.3 |
PHM | 418.6±65.4 | 24.7±1.9 | 17.6 |
HMM | 645.0±98.1a | 47.0±6.4a | 36.4 |
NHM | 740.6±113.5a | 25.0±3.4b | 13.2 |
Abbreviations: HMM, hydroxy-methyl-mexiletine; HP, holding potentials; IC50, half-maximal blocking concentration; Ki, affinity constant for the inactivated state; Kr, affinity constant for the resting state; Mex, mexiletine; NHM, N-hydroxy-mexiletine; NMG, N-carbonyloxy β-D-glucuronide; PHM, p-hydroxy-mexiletine.
The columns from left to right are as follows: drug used; IC50 values a two different HP values: of −140 and −70 mV; inactivated-state block refers to the affinity constants for inactivated sodium channels (Ki) according to the equation in Methods.The IC50 values of each metabolite were significantly different with respect to those of Mex (P<0.001).
a and b show the statistic significance by Student's t-test between the metabolites (for P<0.05 or less) as follows:
With respect to PHM.
With respect to HMM.